tirzepatide original SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Compounded Tirzepatide (GLP-1/GIP)

Tap the syringe gently and expel any air

Aliment Pharmacol Ther 41(4):368378 Reeds DN et al (2003) Alterations in lipid kinetics in men with HIV-dyslipidemia

Patients typically start on 2.5 mg per week, and the endocrinologist and patient decide together when to step up to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg, based on response and tolerance

Rare postmarketing cases of pulmonary aspiration from retained stomach contents have been reported in GLP-1-treated patients, even after following the recommended preoperative fast

All compounds are 99%+ purity, HPLC-verified, and supplied with a lab-issued Certificate of Analysis

Combined with appetite suppression and increased metabolic output, retatrutide triggers deeper fat-cell depletion than single-agonist therapies